Continuous Subcutaneous Neostigmine in the Management of Severe Myasthenia Gravis.

BMJ
doi 10.1136/bmj.1.6170.1050
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Subcutaneous Immunoglobulins Are a Valuable Treatment Option in Myasthenia Gravis

Journal of Clinical Neurology (Korea
Neurology
2018English

Long-Term Treatment of Refractory Myasthenia Gravis With Subcutaneous Immunoglobulin

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2017English

Continuous Remission of Myasthenia Gravis With the Recurrence of Thymoma

Japanese Journal of Clinical Immunology
1986English

Myasthenia Gravis

CMAJ
Medicine
2018English

Myasthenia Gravis

Postgraduate Medical Journal
Medicine
1965English

Myasthenia Gravis

Seminars in Neurology
Neurology
2016English

Myasthenia Gravis

JAMA - Journal of the American Medical Association
Medicine
2005English

Myasthenia Gravis in Children and Anaesthetic Management for Thymectomy

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
1973English

Thymectomy in Myasthenia Gravis

BMJ
1949English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy